Lynn Macdonald

Lynn Macdonald, Ph.D., joined Regeneron in 1999 and serves as senior vice president, research. Dr. Macdonald is responsible for heading the VelocImmune-NEXT technology development group, neuroscience group, molecular profiling & data sciences group, and DNA core & Aautomation group. She has been a key contributor to developing Regeneron’s groundbreaking VelociSuite® of genomics technologies, including playing a critical role in developing VelociGene®, and subsequently working as part of a team that developed the VelocImmune® Mouse. Prior to joining Regeneron, Dr. Macdonald worked for Cadus Pharmaceuticals after completing a post-doctoral fellowship at Columbia University. She earned a B.S. from the University of Rochester and a Ph.D. from State University of New York.